Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2017 | Pages:
102 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
This report studies the global Cancer Biomarkers market, analyzes and researches the Cancer Biomarkers development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Illumina, Inc.
Agilent Technologies
QIAGEN
Merck & Co., Inc.
Hologic, Inc.
Novartis AG
bioMerieux SA
Genomic Health, Inc.
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Cancer Biomarkers can be split into
PSA Tests
CTC Tests
AFP Tests
HER2 Tests
BRCA Tests
ALK Tests
CEA Tests
EGFR Mutation Tests
KRAS Mutation Tests
Others
Market segment by Application, Cancer Biomarkers can be split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Blood Cancer
Prostate Cancer
Ovarian Cancer
Stomach Cancer
Liver Cancer
Others
Table of Contents
Global Cancer Biomarkers Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Biomarkers
1.1 Cancer Biomarkers Market Overview
1.1.1 Cancer Biomarkers Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Biomarkers Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Biomarkers Market by Type
1.3.1 PSA Tests
1.3.2 CTC Tests
1.3.3 AFP Tests
1.3.4 HER2 Tests
1.3.5 BRCA Tests
1.3.6 ALK Tests
1.3.7 CEA Tests
1.3.8 EGFR Mutation Tests
1.3.9 KRAS Mutation Tests
1.3.10 Others
1.4 Cancer Biomarkers Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Lung Cancer
1.4.3 Colorectal Cancer
1.4.4 Melanoma
1.4.5 Blood Cancer
1.4.6 Prostate Cancer
1.4.7 Ovarian Cancer
1.4.8 Stomach Cancer
1.4.9 Liver Cancer
1.4.10 Others
2 Global Cancer Biomarkers Competition Analysis by Players
2.1 Cancer Biomarkers Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Thermo Fisher Scientific Inc.
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche Ltd
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Illumina, Inc.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Agilent Technologies
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 QIAGEN
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Merck & Co., Inc.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Hologic, Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Novartis AG
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 bioMerieux SA
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Biomarkers Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Genomic Health, Inc.
4 Global Cancer Biomarkers Market Size by Type and Application (2012-2017)
4.1 Global Cancer Biomarkers Market Size by Type (2012-2017)
4.2 Global Cancer Biomarkers Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Biomarkers in Future
4.4 Top Consumer/End Users of Cancer Biomarkers
5 United States Cancer Biomarkers Development Status and Outlook
5.1 United States Cancer Biomarkers Market Size (2012-2017)
5.2 United States Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
6 EU Cancer Biomarkers Development Status and Outlook
6.1 EU Cancer Biomarkers Market Size (2012-2017)
6.2 EU Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
7 Japan Cancer Biomarkers Development Status and Outlook
7.1 Japan Cancer Biomarkers Market Size (2012-2017)
7.2 Japan Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
8 China Cancer Biomarkers Development Status and Outlook
8.1 China Cancer Biomarkers Market Size (2012-2017)
8.2 China Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
9 India Cancer Biomarkers Development Status and Outlook
9.1 India Cancer Biomarkers Market Size (2012-2017)
9.2 India Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Cancer Biomarkers Development Status and Outlook
10.1 Southeast Asia Cancer Biomarkers Market Size (2012-2017)
10.2 Southeast Asia Cancer Biomarkers Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Cancer Biomarkers Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Biomarkers Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Biomarkers Market Size (Value) by Type (2017-2022)
11.3 Global Cancer Biomarkers Market Size by Application (2017-2022)
12 Cancer Biomarkers Market Dynamics
12.1 Cancer Biomarkers Market Opportunities
12.2 Cancer Biomarkers Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Biomarkers Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Biomarkers Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Table and Figures
Figure Cancer Biomarkers Product Scope
Figure Global Cancer Biomarkers Market Size (Million USD) (2012-2017)
Table Global Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Biomarkers Market Share by Regions in 2016
Figure United States Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Biomarkers Market Share by Type in 2016
Figure PSA Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure CTC Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure AFP Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure HER2 Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure BRCA Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure ALK Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure CEA Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure EGFR Mutation Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure KRAS Mutation Tests Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cancer Biomarkers Market Share by Application in 2016
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Breast Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Lung Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Colorectal Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Melanoma (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Blood Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Prostate Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Ovarian Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Stomach Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Liver Cancer (2012-2017)
Figure Cancer Biomarkers Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Cancer Biomarkers Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Biomarkers Market Size Share by Players in 2016
Figure Cancer Biomarkers Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Cancer Biomarkers Business Revenue Market Share in 2016
Table Thermo Fisher Scientific Inc. Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Thermo Fisher Scientific Inc. (2012-2017)
Figure Thermo Fisher Scientific Inc. Cancer Biomarkers Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd (2012-2017)
Figure F. Hoffmann-La Roche Ltd Cancer Biomarkers Business Revenue Market Share in 2016
Table Illumina, Inc. Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Illumina, Inc. (2012-2017)
Figure Illumina, Inc. Cancer Biomarkers Business Revenue Market Share in 2016
Table Agilent Technologies Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Agilent Technologies (2012-2017)
Figure Agilent Technologies Cancer Biomarkers Business Revenue Market Share in 2016
Table QIAGEN Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of QIAGEN (2012-2017)
Figure QIAGEN Cancer Biomarkers Business Revenue Market Share in 2016
Table Merck & Co., Inc. Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Merck & Co., Inc. (2012-2017)
Figure Merck & Co., Inc. Cancer Biomarkers Business Revenue Market Share in 2016
Table Hologic, Inc. Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Hologic, Inc. (2012-2017)
Figure Hologic, Inc. Cancer Biomarkers Business Revenue Market Share in 2016
Table Novartis AG Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Cancer Biomarkers Business Revenue Market Share in 2016
Table bioMerieux SA Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of bioMerieux SA (2012-2017)
Figure bioMerieux SA Cancer Biomarkers Business Revenue Market Share in 2016
Table Genomic Health, Inc. Basic Information List
Table Cancer Biomarkers Business Revenue (Million USD) of Genomic Health, Inc. (2012-2017)
Figure Genomic Health, Inc. Cancer Biomarkers Business Revenue Market Share in 2016
Table Global Cancer Biomarkers Market Size (Million USD) by Type (2012-2017)
Figure Global Cancer Biomarkers Market Size Share by Type in 2012
Figure Global Cancer Biomarkers Market Size Share by Type in 2013
Figure Global Cancer Biomarkers Market Size Share by Type in 2014
Figure Global Cancer Biomarkers Market Size Share by Type in 2015
Figure Global Cancer Biomarkers Market Size Share by Type in 2016
Figure Global Cancer Biomarkers Market Size Share by Type in 2017
Table Global Cancer Biomarkers Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2012
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2013
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2014
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2015
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2016
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Biomarkers
Figure United States Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Biomarkers Market Size Share by Players in 2016
Figure United States Cancer Biomarkers Market Size Share by Players in 2017
Figure EU Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Biomarkers Market Size Share by Players in 2016
Figure EU Cancer Biomarkers Market Size Share by Players in 2017
Figure Japan Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Biomarkers Market Size Share by Players in 2016
Figure Japan Cancer Biomarkers Market Size Share by Players in 2017
Figure China Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Biomarkers Market Size Share by Players in 2016
Figure China Cancer Biomarkers Market Size Share by Players in 2017
Figure India Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Biomarkers Market Size Share by Players in 2016
Figure India Cancer Biomarkers Market Size Share by Players in 2017
Figure Southeast Asia Cancer Biomarkers Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Biomarkers Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Biomarkers Market Size Share by Players in 2016
Figure Southeast Asia Cancer Biomarkers Market Size Share by Players in 2017
Figure Global Cancer Biomarkers Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Biomarkers Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Biomarkers Market Size Share by Regions in 2017
Figure Global Cancer Biomarkers Market Size Share by Regions in 2022
Figure United States Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Biomarkers Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Biomarkers Market Size (Million USD) by Type (2017-2022)
Figure Global Cancer Biomarkers Market Size Share by Type in 2017
Figure Global Cancer Biomarkers Market Size Share by Type in 2022
Table Global Cancer Biomarkers Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2017
Figure Global Cancer Biomarkers Market Size (Million USD) by Application in 2022
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
